nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C9—Estropipate—osteoporosis	0.0916	0.149	CbGbCtD
Tolterodine—CYP2C19—Cholecalciferol—osteoporosis	0.0568	0.0921	CbGbCtD
Tolterodine—CYP3A4—Estropipate—osteoporosis	0.0533	0.0864	CbGbCtD
Tolterodine—CYP3A4—Calcitriol—osteoporosis	0.0533	0.0864	CbGbCtD
Tolterodine—CYP2C9—Cholecalciferol—osteoporosis	0.0472	0.0766	CbGbCtD
Tolterodine—CYP2C19—Estradiol—osteoporosis	0.0458	0.0742	CbGbCtD
Tolterodine—CYP2D6—Cholecalciferol—osteoporosis	0.0432	0.07	CbGbCtD
Tolterodine—CYP3A4—Ergocalciferol—osteoporosis	0.0426	0.0691	CbGbCtD
Tolterodine—CYP2C9—Estradiol—osteoporosis	0.038	0.0617	CbGbCtD
Tolterodine—CYP3A4—Raloxifene—osteoporosis	0.0355	0.0577	CbGbCtD
Tolterodine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0343	0.0557	CbGbCtD
Tolterodine—CYP3A4—Cholecalciferol—osteoporosis	0.0274	0.0445	CbGbCtD
Tolterodine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0252	0.0409	CbGbCtD
Tolterodine—CYP3A4—Estradiol—osteoporosis	0.0221	0.0359	CbGbCtD
Tolterodine—Anaphylactoid reaction—Estradiol—osteoporosis	0.00116	0.00333	CcSEcCtD
Tolterodine—Sinusitis—Pamidronate—osteoporosis	0.00115	0.00331	CcSEcCtD
Tolterodine—Angioedema—Alendronate—osteoporosis	0.00115	0.0033	CcSEcCtD
Tolterodine—Vertigo—Estropipate—osteoporosis	0.00115	0.0033	CcSEcCtD
Tolterodine—Visual impairment—Ethinyl Estradiol—osteoporosis	0.00115	0.00329	CcSEcCtD
Tolterodine—Weight increased—Zoledronate—osteoporosis	0.00114	0.00329	CcSEcCtD
Tolterodine—Oedema peripheral—Risedronate—osteoporosis	0.00114	0.00328	CcSEcCtD
Tolterodine—Dysuria—Conjugated Estrogens—osteoporosis	0.00113	0.00325	CcSEcCtD
Tolterodine—Vertigo—Alendronate—osteoporosis	0.00113	0.00325	CcSEcCtD
Tolterodine—Palpitations—Estropipate—osteoporosis	0.00113	0.00324	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.00112	0.00323	CcSEcCtD
Tolterodine—Angioedema—Ibandronate—osteoporosis	0.00112	0.00321	CcSEcCtD
Tolterodine—Vertigo—Raloxifene—osteoporosis	0.00111	0.00319	CcSEcCtD
Tolterodine—Weight increased—Conjugated Estrogens—osteoporosis	0.0011	0.00317	CcSEcCtD
Tolterodine—Vertigo—Ibandronate—osteoporosis	0.0011	0.00316	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.0011	0.00315	CcSEcCtD
Tolterodine—Urinary tract infection—Zoledronate—osteoporosis	0.00109	0.00313	CcSEcCtD
Tolterodine—Arthralgia—Estropipate—osteoporosis	0.00109	0.00312	CcSEcCtD
Tolterodine—Anxiety—Estropipate—osteoporosis	0.00108	0.00311	CcSEcCtD
Tolterodine—Palpitations—Ibandronate—osteoporosis	0.00108	0.00311	CcSEcCtD
Tolterodine—Chest pain—Alendronate—osteoporosis	0.00107	0.00308	CcSEcCtD
Tolterodine—Dyspepsia—Etidronic acid—osteoporosis	0.00106	0.00305	CcSEcCtD
Tolterodine—Chest pain—Raloxifene—osteoporosis	0.00105	0.00303	CcSEcCtD
Tolterodine—Arthralgia—Raloxifene—osteoporosis	0.00105	0.00303	CcSEcCtD
Tolterodine—Arthralgia—Ibandronate—osteoporosis	0.00104	0.003	CcSEcCtD
Tolterodine—Chest pain—Ibandronate—osteoporosis	0.00104	0.003	CcSEcCtD
Tolterodine—Oedema—Estropipate—osteoporosis	0.00104	0.00299	CcSEcCtD
Tolterodine—Anaphylactic shock—Estropipate—osteoporosis	0.00104	0.00299	CcSEcCtD
Tolterodine—Anxiety—Ibandronate—osteoporosis	0.00104	0.00298	CcSEcCtD
Tolterodine—Infection—Estropipate—osteoporosis	0.00103	0.00297	CcSEcCtD
Tolterodine—Constipation—Etidronic acid—osteoporosis	0.00103	0.00296	CcSEcCtD
Tolterodine—Dry skin—Estradiol—osteoporosis	0.00103	0.00295	CcSEcCtD
Tolterodine—Flushing—Pamidronate—osteoporosis	0.00102	0.00294	CcSEcCtD
Tolterodine—Chest pain—Calcitriol—osteoporosis	0.00102	0.00293	CcSEcCtD
Tolterodine—Infection—Alendronate—osteoporosis	0.00102	0.00293	CcSEcCtD
Tolterodine—Dry mouth—Ibandronate—osteoporosis	0.00102	0.00293	CcSEcCtD
Tolterodine—Anxiety—Calcitriol—osteoporosis	0.00102	0.00292	CcSEcCtD
Tolterodine—Sinusitis—Conjugated Estrogens—osteoporosis	0.00101	0.00291	CcSEcCtD
Tolterodine—Infection—Raloxifene—osteoporosis	0.001	0.00288	CcSEcCtD
Tolterodine—Anaphylactic shock—Ibandronate—osteoporosis	0.000999	0.00287	CcSEcCtD
Tolterodine—Dry mouth—Calcitriol—osteoporosis	0.000997	0.00287	CcSEcCtD
Tolterodine—Flatulence—Risedronate—osteoporosis	0.000994	0.00286	CcSEcCtD
Tolterodine—Infection—Ibandronate—osteoporosis	0.000992	0.00285	CcSEcCtD
Tolterodine—Feeling abnormal—Etidronic acid—osteoporosis	0.000992	0.00285	CcSEcCtD
Tolterodine—Oedema peripheral—Zoledronate—osteoporosis	0.000991	0.00285	CcSEcCtD
Tolterodine—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000984	0.00283	CcSEcCtD
Tolterodine—Anaphylactic shock—Calcitriol—osteoporosis	0.000978	0.00281	CcSEcCtD
Tolterodine—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000954	0.00274	CcSEcCtD
Tolterodine—Abdominal pain—Etidronic acid—osteoporosis	0.000952	0.00274	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000949	0.00273	CcSEcCtD
Tolterodine—Angioedema—Ethinyl Estradiol—osteoporosis	0.000945	0.00272	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000935	0.00269	CcSEcCtD
Tolterodine—Flushing—Zoledronate—osteoporosis	0.000934	0.00268	CcSEcCtD
Tolterodine—Visual impairment—Conjugated Estrogens—osteoporosis	0.000933	0.00268	CcSEcCtD
Tolterodine—Bronchitis—Estradiol—osteoporosis	0.000931	0.00268	CcSEcCtD
Tolterodine—Somnolence—Estropipate—osteoporosis	0.000926	0.00266	CcSEcCtD
Tolterodine—Angioedema—Risedronate—osteoporosis	0.000922	0.00265	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000919	0.00264	CcSEcCtD
Tolterodine—Dyspepsia—Estropipate—osteoporosis	0.000917	0.00264	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00091	0.00262	CcSEcCtD
Tolterodine—Vertigo—Risedronate—osteoporosis	0.000906	0.00261	CcSEcCtD
Tolterodine—Dyspepsia—Alendronate—osteoporosis	0.000903	0.0026	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Estradiol—osteoporosis	0.0009	0.00259	CcSEcCtD
Tolterodine—Fatigue—Estropipate—osteoporosis	0.000898	0.00258	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000891	0.00256	CcSEcCtD
Tolterodine—Pain—Estropipate—osteoporosis	0.000891	0.00256	CcSEcCtD
Tolterodine—Constipation—Estropipate—osteoporosis	0.000891	0.00256	CcSEcCtD
Tolterodine—Dyspepsia—Raloxifene—osteoporosis	0.000888	0.00255	CcSEcCtD
Tolterodine—Hypersensitivity—Etidronic acid—osteoporosis	0.000887	0.00255	CcSEcCtD
Tolterodine—Weight increased—Estradiol—osteoporosis	0.000881	0.00253	CcSEcCtD
Tolterodine—Dyspepsia—Ibandronate—osteoporosis	0.000879	0.00253	CcSEcCtD
Tolterodine—Anxiety—Ethinyl Estradiol—osteoporosis	0.000878	0.00252	CcSEcCtD
Tolterodine—Pain—Alendronate—osteoporosis	0.000877	0.00252	CcSEcCtD
Tolterodine—Constipation—Alendronate—osteoporosis	0.000877	0.00252	CcSEcCtD
Tolterodine—Angioedema—Pamidronate—osteoporosis	0.000876	0.00252	CcSEcCtD
Tolterodine—Somnolence—Calcitriol—osteoporosis	0.000869	0.0025	CcSEcCtD
Tolterodine—Pain—Raloxifene—osteoporosis	0.000863	0.00248	CcSEcCtD
Tolterodine—Fatigue—Ibandronate—osteoporosis	0.000861	0.00248	CcSEcCtD
Tolterodine—Arthralgia—Risedronate—osteoporosis	0.000859	0.00247	CcSEcCtD
Tolterodine—Chest pain—Risedronate—osteoporosis	0.000859	0.00247	CcSEcCtD
Tolterodine—Anxiety—Risedronate—osteoporosis	0.000856	0.00246	CcSEcCtD
Tolterodine—Constipation—Ibandronate—osteoporosis	0.000854	0.00246	CcSEcCtD
Tolterodine—Pain—Ibandronate—osteoporosis	0.000854	0.00246	CcSEcCtD
Tolterodine—Gastrointestinal pain—Estropipate—osteoporosis	0.000852	0.00245	CcSEcCtD
Tolterodine—Feeling abnormal—Alendronate—osteoporosis	0.000845	0.00243	CcSEcCtD
Tolterodine—Oedema—Ethinyl Estradiol—osteoporosis	0.000844	0.00243	CcSEcCtD
Tolterodine—Dry mouth—Risedronate—osteoporosis	0.00084	0.00241	CcSEcCtD
Tolterodine—Urinary tract infection—Estradiol—osteoporosis	0.000839	0.00241	CcSEcCtD
Tolterodine—Gastrointestinal pain—Alendronate—osteoporosis	0.000839	0.00241	CcSEcCtD
Tolterodine—Infection—Ethinyl Estradiol—osteoporosis	0.000839	0.00241	CcSEcCtD
Tolterodine—Pain—Calcitriol—osteoporosis	0.000836	0.0024	CcSEcCtD
Tolterodine—Constipation—Calcitriol—osteoporosis	0.000836	0.0024	CcSEcCtD
Tolterodine—Flatulence—Conjugated Estrogens—osteoporosis	0.000831	0.00239	CcSEcCtD
Tolterodine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000825	0.00237	CcSEcCtD
Tolterodine—Diarrhoea—Etidronic acid—osteoporosis	0.000824	0.00237	CcSEcCtD
Tolterodine—Abdominal pain—Estropipate—osteoporosis	0.000823	0.00237	CcSEcCtD
Tolterodine—Feeling abnormal—Ibandronate—osteoporosis	0.000823	0.00237	CcSEcCtD
Tolterodine—Infection—Risedronate—osteoporosis	0.000818	0.00235	CcSEcCtD
Tolterodine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000817	0.00235	CcSEcCtD
Tolterodine—Arthralgia—Pamidronate—osteoporosis	0.000816	0.00235	CcSEcCtD
Tolterodine—Anxiety—Pamidronate—osteoporosis	0.000813	0.00234	CcSEcCtD
Tolterodine—Abdominal pain—Alendronate—osteoporosis	0.000811	0.00233	CcSEcCtD
Tolterodine—Sinusitis—Estradiol—osteoporosis	0.00081	0.00233	CcSEcCtD
Tolterodine—Angioedema—Zoledronate—osteoporosis	0.0008	0.0023	CcSEcCtD
Tolterodine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000799	0.0023	CcSEcCtD
Tolterodine—Abdominal pain—Raloxifene—osteoporosis	0.000798	0.00229	CcSEcCtD
Tolterodine—Abdominal pain—Ibandronate—osteoporosis	0.00079	0.00227	CcSEcCtD
Tolterodine—Confusional state—Pamidronate—osteoporosis	0.000789	0.00227	CcSEcCtD
Tolterodine—Vertigo—Zoledronate—osteoporosis	0.000787	0.00226	CcSEcCtD
Tolterodine—Oedema—Pamidronate—osteoporosis	0.000782	0.00225	CcSEcCtD
Tolterodine—Anaphylactic shock—Pamidronate—osteoporosis	0.000782	0.00225	CcSEcCtD
Tolterodine—Infection—Pamidronate—osteoporosis	0.000777	0.00223	CcSEcCtD
Tolterodine—Palpitations—Zoledronate—osteoporosis	0.000774	0.00222	CcSEcCtD
Tolterodine—Abdominal pain—Calcitriol—osteoporosis	0.000773	0.00222	CcSEcCtD
Tolterodine—Angioedema—Conjugated Estrogens—osteoporosis	0.000771	0.00222	CcSEcCtD
Tolterodine—Hypersensitivity—Estropipate—osteoporosis	0.000767	0.00221	CcSEcCtD
Tolterodine—Oedema peripheral—Estradiol—osteoporosis	0.000764	0.0022	CcSEcCtD
Tolterodine—Tachycardia—Pamidronate—osteoporosis	0.000764	0.0022	CcSEcCtD
Tolterodine—Vertigo—Conjugated Estrogens—osteoporosis	0.000758	0.00218	CcSEcCtD
Tolterodine—Hypersensitivity—Alendronate—osteoporosis	0.000756	0.00217	CcSEcCtD
Tolterodine—Headache—Etidronic acid—osteoporosis	0.000754	0.00217	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00075	0.00216	CcSEcCtD
Tolterodine—Asthenia—Estropipate—osteoporosis	0.000747	0.00215	CcSEcCtD
Tolterodine—Visual impairment—Estradiol—osteoporosis	0.000747	0.00215	CcSEcCtD
Tolterodine—Arthralgia—Zoledronate—osteoporosis	0.000746	0.00214	CcSEcCtD
Tolterodine—Chest pain—Zoledronate—osteoporosis	0.000746	0.00214	CcSEcCtD
Tolterodine—Palpitations—Conjugated Estrogens—osteoporosis	0.000745	0.00214	CcSEcCtD
Tolterodine—Anxiety—Zoledronate—osteoporosis	0.000743	0.00214	CcSEcCtD
Tolterodine—Asthenia—Alendronate—osteoporosis	0.000736	0.00212	CcSEcCtD
Tolterodine—Hypersensitivity—Ibandronate—osteoporosis	0.000736	0.00212	CcSEcCtD
Tolterodine—Dry mouth—Zoledronate—osteoporosis	0.000729	0.0021	CcSEcCtD
Tolterodine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000728	0.00209	CcSEcCtD
Tolterodine—Dyspepsia—Risedronate—osteoporosis	0.000725	0.00208	CcSEcCtD
Tolterodine—Constipation—Ethinyl Estradiol—osteoporosis	0.000722	0.00208	CcSEcCtD
Tolterodine—Confusional state—Zoledronate—osteoporosis	0.000721	0.00207	CcSEcCtD
Tolterodine—Hypersensitivity—Calcitriol—osteoporosis	0.00072	0.00207	CcSEcCtD
Tolterodine—Flushing—Estradiol—osteoporosis	0.00072	0.00207	CcSEcCtD
Tolterodine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000718	0.00206	CcSEcCtD
Tolterodine—Chest pain—Conjugated Estrogens—osteoporosis	0.000718	0.00206	CcSEcCtD
Tolterodine—Asthenia—Ibandronate—osteoporosis	0.000717	0.00206	CcSEcCtD
Tolterodine—Anxiety—Conjugated Estrogens—osteoporosis	0.000715	0.00206	CcSEcCtD
Tolterodine—Oedema—Zoledronate—osteoporosis	0.000715	0.00205	CcSEcCtD
Tolterodine—Anaphylactic shock—Zoledronate—osteoporosis	0.000715	0.00205	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000713	0.00205	CcSEcCtD
Tolterodine—Diarrhoea—Estropipate—osteoporosis	0.000713	0.00205	CcSEcCtD
Tolterodine—Infection—Zoledronate—osteoporosis	0.00071	0.00204	CcSEcCtD
Tolterodine—Fatigue—Risedronate—osteoporosis	0.00071	0.00204	CcSEcCtD
Tolterodine—Pain—Risedronate—osteoporosis	0.000704	0.00202	CcSEcCtD
Tolterodine—Constipation—Risedronate—osteoporosis	0.000704	0.00202	CcSEcCtD
Tolterodine—Diarrhoea—Alendronate—osteoporosis	0.000702	0.00202	CcSEcCtD
Tolterodine—Asthenia—Calcitriol—osteoporosis	0.000701	0.00202	CcSEcCtD
Tolterodine—Tachycardia—Zoledronate—osteoporosis	0.000698	0.00201	CcSEcCtD
Tolterodine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000696	0.002	CcSEcCtD
Tolterodine—Somnolence—Pamidronate—osteoporosis	0.000696	0.002	CcSEcCtD
Tolterodine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00069	0.00198	CcSEcCtD
Tolterodine—Diarrhoea—Raloxifene—osteoporosis	0.00069	0.00198	CcSEcCtD
Tolterodine—Dyspepsia—Pamidronate—osteoporosis	0.000689	0.00198	CcSEcCtD
Tolterodine—Dizziness—Estropipate—osteoporosis	0.000689	0.00198	CcSEcCtD
Tolterodine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000688	0.00198	CcSEcCtD
Tolterodine—Oedema—Conjugated Estrogens—osteoporosis	0.000688	0.00198	CcSEcCtD
Tolterodine—Infection—Conjugated Estrogens—osteoporosis	0.000684	0.00197	CcSEcCtD
Tolterodine—Diarrhoea—Ibandronate—osteoporosis	0.000683	0.00196	CcSEcCtD
Tolterodine—Dizziness—Alendronate—osteoporosis	0.000678	0.00195	CcSEcCtD
Tolterodine—Fatigue—Pamidronate—osteoporosis	0.000675	0.00194	CcSEcCtD
Tolterodine—Gastrointestinal pain—Risedronate—osteoporosis	0.000673	0.00194	CcSEcCtD
Tolterodine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000672	0.00193	CcSEcCtD
Tolterodine—Pain—Pamidronate—osteoporosis	0.000669	0.00192	CcSEcCtD
Tolterodine—Constipation—Pamidronate—osteoporosis	0.000669	0.00192	CcSEcCtD
Tolterodine—Diarrhoea—Calcitriol—osteoporosis	0.000669	0.00192	CcSEcCtD
Tolterodine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000667	0.00192	CcSEcCtD
Tolterodine—Dizziness—Raloxifene—osteoporosis	0.000667	0.00192	CcSEcCtD
Tolterodine—Flatulence—Estradiol—osteoporosis	0.000665	0.00191	CcSEcCtD
Tolterodine—Dizziness—Ibandronate—osteoporosis	0.00066	0.0019	CcSEcCtD
Tolterodine—Headache—Estropipate—osteoporosis	0.000652	0.00188	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000651	0.00187	CcSEcCtD
Tolterodine—Abdominal pain—Risedronate—osteoporosis	0.000651	0.00187	CcSEcCtD
Tolterodine—Feeling abnormal—Pamidronate—osteoporosis	0.000645	0.00185	CcSEcCtD
Tolterodine—Headache—Alendronate—osteoporosis	0.000643	0.00185	CcSEcCtD
Tolterodine—Gastrointestinal pain—Pamidronate—osteoporosis	0.00064	0.00184	CcSEcCtD
Tolterodine—Somnolence—Zoledronate—osteoporosis	0.000635	0.00183	CcSEcCtD
Tolterodine—Headache—Raloxifene—osteoporosis	0.000632	0.00182	CcSEcCtD
Tolterodine—Dyspepsia—Zoledronate—osteoporosis	0.000629	0.00181	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000627	0.0018	CcSEcCtD
Tolterodine—Headache—Ibandronate—osteoporosis	0.000626	0.0018	CcSEcCtD
Tolterodine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000622	0.00179	CcSEcCtD
Tolterodine—Abdominal pain—Pamidronate—osteoporosis	0.000619	0.00178	CcSEcCtD
Tolterodine—Angioedema—Estradiol—osteoporosis	0.000617	0.00177	CcSEcCtD
Tolterodine—Fatigue—Zoledronate—osteoporosis	0.000616	0.00177	CcSEcCtD
Tolterodine—Headache—Calcitriol—osteoporosis	0.000612	0.00176	CcSEcCtD
Tolterodine—Somnolence—Conjugated Estrogens—osteoporosis	0.000612	0.00176	CcSEcCtD
Tolterodine—Constipation—Zoledronate—osteoporosis	0.000611	0.00176	CcSEcCtD
Tolterodine—Pain—Zoledronate—osteoporosis	0.000611	0.00176	CcSEcCtD
Tolterodine—Hypersensitivity—Risedronate—osteoporosis	0.000606	0.00174	CcSEcCtD
Tolterodine—Vertigo—Estradiol—osteoporosis	0.000606	0.00174	CcSEcCtD
Tolterodine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000606	0.00174	CcSEcCtD
Tolterodine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000606	0.00174	CcSEcCtD
Tolterodine—Palpitations—Estradiol—osteoporosis	0.000596	0.00171	CcSEcCtD
Tolterodine—Fatigue—Conjugated Estrogens—osteoporosis	0.000593	0.00171	CcSEcCtD
Tolterodine—Asthenia—Risedronate—osteoporosis	0.000591	0.0017	CcSEcCtD
Tolterodine—Feeling abnormal—Zoledronate—osteoporosis	0.000589	0.00169	CcSEcCtD
Tolterodine—Constipation—Conjugated Estrogens—osteoporosis	0.000589	0.00169	CcSEcCtD
Tolterodine—Pain—Conjugated Estrogens—osteoporosis	0.000589	0.00169	CcSEcCtD
Tolterodine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000584	0.00168	CcSEcCtD
Tolterodine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000578	0.00166	CcSEcCtD
Tolterodine—Hypersensitivity—Pamidronate—osteoporosis	0.000576	0.00166	CcSEcCtD
Tolterodine—Arthralgia—Estradiol—osteoporosis	0.000575	0.00165	CcSEcCtD
Tolterodine—Chest pain—Estradiol—osteoporosis	0.000575	0.00165	CcSEcCtD
Tolterodine—Anxiety—Estradiol—osteoporosis	0.000573	0.00165	CcSEcCtD
Tolterodine—Abdominal pain—Zoledronate—osteoporosis	0.000565	0.00162	CcSEcCtD
Tolterodine—Diarrhoea—Risedronate—osteoporosis	0.000563	0.00162	CcSEcCtD
Tolterodine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000563	0.00162	CcSEcCtD
Tolterodine—Dry mouth—Estradiol—osteoporosis	0.000562	0.00162	CcSEcCtD
Tolterodine—Asthenia—Pamidronate—osteoporosis	0.000561	0.00161	CcSEcCtD
Tolterodine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000558	0.0016	CcSEcCtD
Tolterodine—Confusional state—Estradiol—osteoporosis	0.000555	0.0016	CcSEcCtD
Tolterodine—Anaphylactic shock—Estradiol—osteoporosis	0.000551	0.00158	CcSEcCtD
Tolterodine—Oedema—Estradiol—osteoporosis	0.000551	0.00158	CcSEcCtD
Tolterodine—Infection—Estradiol—osteoporosis	0.000547	0.00157	CcSEcCtD
Tolterodine—Dizziness—Risedronate—osteoporosis	0.000544	0.00156	CcSEcCtD
Tolterodine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000544	0.00156	CcSEcCtD
Tolterodine—Tachycardia—Estradiol—osteoporosis	0.000538	0.00155	CcSEcCtD
Tolterodine—Diarrhoea—Pamidronate—osteoporosis	0.000535	0.00154	CcSEcCtD
Tolterodine—Headache—Ethinyl Estradiol—osteoporosis	0.000529	0.00152	CcSEcCtD
Tolterodine—Hypersensitivity—Zoledronate—osteoporosis	0.000527	0.00151	CcSEcCtD
Tolterodine—Dizziness—Pamidronate—osteoporosis	0.000517	0.00149	CcSEcCtD
Tolterodine—Headache—Risedronate—osteoporosis	0.000516	0.00148	CcSEcCtD
Tolterodine—Asthenia—Zoledronate—osteoporosis	0.000513	0.00147	CcSEcCtD
Tolterodine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000507	0.00146	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000502	0.00144	CcSEcCtD
Tolterodine—Asthenia—Conjugated Estrogens—osteoporosis	0.000494	0.00142	CcSEcCtD
Tolterodine—Headache—Pamidronate—osteoporosis	0.00049	0.00141	CcSEcCtD
Tolterodine—Somnolence—Estradiol—osteoporosis	0.00049	0.00141	CcSEcCtD
Tolterodine—Diarrhoea—Zoledronate—osteoporosis	0.000489	0.00141	CcSEcCtD
Tolterodine—Dyspepsia—Estradiol—osteoporosis	0.000485	0.00139	CcSEcCtD
Tolterodine—Fatigue—Estradiol—osteoporosis	0.000475	0.00137	CcSEcCtD
Tolterodine—Dizziness—Zoledronate—osteoporosis	0.000473	0.00136	CcSEcCtD
Tolterodine—Constipation—Estradiol—osteoporosis	0.000471	0.00135	CcSEcCtD
Tolterodine—Pain—Estradiol—osteoporosis	0.000471	0.00135	CcSEcCtD
Tolterodine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000471	0.00135	CcSEcCtD
Tolterodine—Dizziness—Conjugated Estrogens—osteoporosis	0.000455	0.00131	CcSEcCtD
Tolterodine—Feeling abnormal—Estradiol—osteoporosis	0.000454	0.0013	CcSEcCtD
Tolterodine—Gastrointestinal pain—Estradiol—osteoporosis	0.00045	0.00129	CcSEcCtD
Tolterodine—Headache—Zoledronate—osteoporosis	0.000448	0.00129	CcSEcCtD
Tolterodine—Abdominal pain—Estradiol—osteoporosis	0.000435	0.00125	CcSEcCtD
Tolterodine—Headache—Conjugated Estrogens—osteoporosis	0.000431	0.00124	CcSEcCtD
Tolterodine—Hypersensitivity—Estradiol—osteoporosis	0.000406	0.00117	CcSEcCtD
Tolterodine—Asthenia—Estradiol—osteoporosis	0.000395	0.00114	CcSEcCtD
Tolterodine—Diarrhoea—Estradiol—osteoporosis	0.000377	0.00108	CcSEcCtD
Tolterodine—Dizziness—Estradiol—osteoporosis	0.000364	0.00105	CcSEcCtD
Tolterodine—Headache—Estradiol—osteoporosis	0.000345	0.000992	CcSEcCtD
Tolterodine—CHRM1—Signaling by GPCR—CALCA—osteoporosis	2.76e-05	0.000769	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CALCA—osteoporosis	2.75e-05	0.000766	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PTHLH—osteoporosis	2.74e-05	0.000765	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—BMP2—osteoporosis	2.74e-05	0.000765	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—P4HB—osteoporosis	2.73e-05	0.000763	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CALCA—osteoporosis	2.72e-05	0.000759	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GAPDH—osteoporosis	2.68e-05	0.000749	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—OXCT1—osteoporosis	2.68e-05	0.000749	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CA2—osteoporosis	2.68e-05	0.000749	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—FGB—osteoporosis	2.68e-05	0.000749	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TLN1—osteoporosis	2.66e-05	0.000742	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TLN1—osteoporosis	2.65e-05	0.00074	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PTHLH—osteoporosis	2.63e-05	0.000733	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—BMP2—osteoporosis	2.63e-05	0.000733	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TLN1—osteoporosis	2.63e-05	0.000733	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MGLL—osteoporosis	2.61e-05	0.00073	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—RAP1A—osteoporosis	2.61e-05	0.000729	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PSMA2—osteoporosis	2.59e-05	0.000723	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PSMA5—osteoporosis	2.59e-05	0.000723	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—FGB—osteoporosis	2.57e-05	0.000717	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PSMA2—osteoporosis	2.48e-05	0.000692	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PSMA5—osteoporosis	2.48e-05	0.000692	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CA2—osteoporosis	2.47e-05	0.000689	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—OXCT1—osteoporosis	2.47e-05	0.000689	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.47e-05	0.000688	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—OXCT1—osteoporosis	2.45e-05	0.000683	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CA2—osteoporosis	2.45e-05	0.000683	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CALCA—osteoporosis	2.41e-05	0.000674	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MGLL—osteoporosis	2.41e-05	0.000671	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MGLL—osteoporosis	2.38e-05	0.000665	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—POMC—osteoporosis	2.35e-05	0.000657	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—POMC—osteoporosis	2.32e-05	0.000648	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CALCA—osteoporosis	2.31e-05	0.000645	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—P4HB—osteoporosis	2.29e-05	0.00064	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—P4HB—osteoporosis	2.29e-05	0.000638	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—IL6—osteoporosis	2.28e-05	0.000638	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—P4HB—osteoporosis	2.26e-05	0.000632	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—POMC—osteoporosis	2.25e-05	0.000629	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.25e-05	0.000627	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PTH—osteoporosis	2.23e-05	0.000623	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PTH—osteoporosis	2.22e-05	0.000621	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—IDH2—osteoporosis	2.22e-05	0.00062	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PTH—osteoporosis	2.2e-05	0.000615	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RAP1A—osteoporosis	2.19e-05	0.000612	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—KL—osteoporosis	2.19e-05	0.000612	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PKM—osteoporosis	2.19e-05	0.000611	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—FDPS—osteoporosis	2.19e-05	0.000611	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RAP1A—osteoporosis	2.19e-05	0.00061	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CNR2—osteoporosis	2.17e-05	0.000607	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CNR2—osteoporosis	2.17e-05	0.000605	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.16e-05	0.000604	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RAP1A—osteoporosis	2.16e-05	0.000604	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	2.16e-05	0.000602	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.16e-05	0.000602	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	2.15e-05	0.0006	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CNR2—osteoporosis	2.15e-05	0.000599	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NFATC1—osteoporosis	2.14e-05	0.000597	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—POMC—osteoporosis	2.14e-05	0.000597	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NFATC1—osteoporosis	2.13e-05	0.000595	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	2.13e-05	0.000595	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—DKK1—osteoporosis	2.12e-05	0.000592	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—DKK1—osteoporosis	2.12e-05	0.00059	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ENO1—osteoporosis	2.11e-05	0.00059	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	2.11e-05	0.000589	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—KL—osteoporosis	2.1e-05	0.000586	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—DKK1—osteoporosis	2.09e-05	0.000585	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.09e-05	0.000583	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6R—osteoporosis	2.09e-05	0.000582	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PSMA5—osteoporosis	2.08e-05	0.000581	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PSMA2—osteoporosis	2.08e-05	0.000581	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GPD2—osteoporosis	2.07e-05	0.000579	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PGLS—osteoporosis	2.07e-05	0.000579	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—POMC—osteoporosis	2.05e-05	0.000571	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—IDH2—osteoporosis	2.05e-05	0.000571	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—WNT1—osteoporosis	2.04e-05	0.00057	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—WNT1—osteoporosis	2.04e-05	0.000569	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ACP5—osteoporosis	2.03e-05	0.000567	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—IDH2—osteoporosis	2.03e-05	0.000566	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—WNT1—osteoporosis	2.02e-05	0.000563	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.01e-05	0.00056	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6R—osteoporosis	2e-05	0.000557	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FGA—osteoporosis	1.99e-05	0.000555	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FGA—osteoporosis	1.98e-05	0.000553	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FGA—osteoporosis	1.96e-05	0.000548	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	1.96e-05	0.000547	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	1.95e-05	0.000545	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	1.93e-05	0.00054	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.92e-05	0.000537	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.91e-05	0.000532	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ATIC—osteoporosis	1.9e-05	0.00053	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PNP—osteoporosis	1.9e-05	0.00053	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—TPI1—osteoporosis	1.89e-05	0.000528	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ACP5—osteoporosis	1.87e-05	0.000522	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ACP5—osteoporosis	1.85e-05	0.000517	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—BMP2—osteoporosis	1.85e-05	0.000516	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PTHLH—osteoporosis	1.85e-05	0.000516	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PTHLH—osteoporosis	1.84e-05	0.000514	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—BMP2—osteoporosis	1.84e-05	0.000514	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.83e-05	0.000511	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	1.82e-05	0.000509	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—BMP2—osteoporosis	1.82e-05	0.000509	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FGB—osteoporosis	1.81e-05	0.000505	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FGB—osteoporosis	1.8e-05	0.000503	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FGB—osteoporosis	1.79e-05	0.000498	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—P4HB—osteoporosis	1.78e-05	0.000496	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PSMA2—osteoporosis	1.75e-05	0.000487	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PSMA5—osteoporosis	1.75e-05	0.000487	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.74e-05	0.000487	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PSMA2—osteoporosis	1.74e-05	0.000486	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PSMA5—osteoporosis	1.74e-05	0.000486	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TPI1—osteoporosis	1.74e-05	0.000485	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	1.72e-05	0.000481	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	1.72e-05	0.000481	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TPI1—osteoporosis	1.72e-05	0.000481	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ADCY5—osteoporosis	1.72e-05	0.000479	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.7e-05	0.000474	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CYP19A1—osteoporosis	1.69e-05	0.000471	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SPP1—osteoporosis	1.66e-05	0.000464	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ADCY5—osteoporosis	1.64e-05	0.000459	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—P4HB—osteoporosis	1.63e-05	0.000456	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CALCA—osteoporosis	1.63e-05	0.000454	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CALCA—osteoporosis	1.62e-05	0.000453	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—P4HB—osteoporosis	1.62e-05	0.000452	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CA2—osteoporosis	1.61e-05	0.00045	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.61e-05	0.00045	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CALCA—osteoporosis	1.61e-05	0.000448	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.6e-05	0.000448	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.59e-05	0.000444	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SPP1—osteoporosis	1.59e-05	0.000444	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—POMC—osteoporosis	1.59e-05	0.000443	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—POMC—osteoporosis	1.58e-05	0.000442	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MGLL—osteoporosis	1.57e-05	0.000439	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	1.57e-05	0.000437	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.56e-05	0.000436	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.55e-05	0.000432	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IRS2—osteoporosis	1.5e-05	0.000419	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.48e-05	0.000414	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—KL—osteoporosis	1.48e-05	0.000412	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—KL—osteoporosis	1.47e-05	0.000411	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—LEP—osteoporosis	1.47e-05	0.00041	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—KL—osteoporosis	1.46e-05	0.000407	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—POMC—osteoporosis	1.44e-05	0.000402	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IRS2—osteoporosis	1.44e-05	0.000401	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—POMC—osteoporosis	1.44e-05	0.000401	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—POMC—osteoporosis	1.42e-05	0.000397	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—LEP—osteoporosis	1.41e-05	0.000393	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6R—osteoporosis	1.41e-05	0.000392	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ESR1—osteoporosis	1.4e-05	0.000392	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6R—osteoporosis	1.4e-05	0.000391	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	1.39e-05	0.000387	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ADCY5—osteoporosis	1.38e-05	0.000385	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GPX1—osteoporosis	1.38e-05	0.000384	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ENO1—osteoporosis	1.37e-05	0.000383	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.35e-05	0.000378	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.35e-05	0.000378	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.35e-05	0.000377	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ESR1—osteoporosis	1.34e-05	0.000375	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—IDH2—osteoporosis	1.34e-05	0.000373	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IRS1—osteoporosis	1.31e-05	0.000366	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MTHFR—osteoporosis	1.27e-05	0.000354	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ENO1—osteoporosis	1.26e-05	0.000353	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—POMC—osteoporosis	1.26e-05	0.000352	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.26e-05	0.000351	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IRS1—osteoporosis	1.26e-05	0.00035	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ENO1—osteoporosis	1.25e-05	0.00035	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.24e-05	0.000347	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.24e-05	0.000347	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.23e-05	0.000344	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.23e-05	0.000344	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6R—osteoporosis	1.23e-05	0.000344	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ACP5—osteoporosis	1.22e-05	0.000341	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF1—osteoporosis	1.21e-05	0.000339	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—POMC—osteoporosis	1.21e-05	0.000338	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6R—osteoporosis	1.18e-05	0.000329	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF1—osteoporosis	1.16e-05	0.000325	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	1.16e-05	0.000323	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	1.15e-05	0.000322	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.14e-05	0.000319	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TPI1—osteoporosis	1.14e-05	0.000317	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SPP1—osteoporosis	1.12e-05	0.000313	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SPP1—osteoporosis	1.12e-05	0.000312	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.11e-05	0.000309	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.1e-05	0.000306	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—P4HB—osteoporosis	1.07e-05	0.000298	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.05e-05	0.000293	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.02e-05	0.000285	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—POMC—osteoporosis	1.02e-05	0.000283	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IRS2—osteoporosis	1.01e-05	0.000283	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.01e-05	0.000282	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IRS2—osteoporosis	1.01e-05	0.000282	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP19A1—osteoporosis	1e-05	0.000279	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IRS2—osteoporosis	1e-05	0.000279	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—LEP—osteoporosis	9.91e-06	0.000277	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—LEP—osteoporosis	9.88e-06	0.000276	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—LEP—osteoporosis	9.79e-06	0.000273	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ESR1—osteoporosis	9.46e-06	0.000264	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ESR1—osteoporosis	9.43e-06	0.000263	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ESR1—osteoporosis	9.34e-06	0.000261	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—IL6—osteoporosis	9.29e-06	0.000259	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ADCY5—osteoporosis	8.97e-06	0.00025	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GPX1—osteoporosis	8.94e-06	0.00025	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—IL6—osteoporosis	8.9e-06	0.000248	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IRS1—osteoporosis	8.84e-06	0.000247	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IRS1—osteoporosis	8.82e-06	0.000246	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IRS1—osteoporosis	8.73e-06	0.000244	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—POMC—osteoporosis	8.52e-06	0.000238	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—POMC—osteoporosis	8.49e-06	0.000237	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—POMC—osteoporosis	8.41e-06	0.000235	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6R—osteoporosis	8.31e-06	0.000232	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6R—osteoporosis	8.28e-06	0.000231	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ENO1—osteoporosis	8.26e-06	0.000231	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ADCY5—osteoporosis	8.25e-06	0.00023	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MTHFR—osteoporosis	8.25e-06	0.00023	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GPX1—osteoporosis	8.22e-06	0.00023	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6R—osteoporosis	8.2e-06	0.000229	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1—osteoporosis	8.19e-06	0.000229	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ADCY5—osteoporosis	8.18e-06	0.000228	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1—osteoporosis	8.17e-06	0.000228	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GPX1—osteoporosis	8.15e-06	0.000228	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PSMA2—osteoporosis	8.14e-06	0.000227	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PSMA5—osteoporosis	8.14e-06	0.000227	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1—osteoporosis	8.09e-06	0.000226	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MTHFR—osteoporosis	7.59e-06	0.000212	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MTHFR—osteoporosis	7.52e-06	0.00021	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MYC—osteoporosis	7.3e-06	0.000204	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TGFB1—osteoporosis	7.28e-06	0.000203	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MYC—osteoporosis	6.99e-06	0.000195	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TGFB1—osteoporosis	6.97e-06	0.000195	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.6e-06	0.000184	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—POMC—osteoporosis	6.6e-06	0.000184	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—IL6—osteoporosis	6.26e-06	0.000175	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—IL6—osteoporosis	6.24e-06	0.000174	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—IL6—osteoporosis	6.18e-06	0.000173	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—POMC—osteoporosis	6.07e-06	0.000169	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—POMC—osteoporosis	6.02e-06	0.000168	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6—osteoporosis	5.49e-06	0.000153	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ADCY5—osteoporosis	5.4e-06	0.000151	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GPX1—osteoporosis	5.38e-06	0.00015	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6—osteoporosis	5.26e-06	0.000147	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MTHFR—osteoporosis	4.96e-06	0.000138	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MYC—osteoporosis	4.92e-06	0.000137	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	4.91e-06	0.000137	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MYC—osteoporosis	4.91e-06	0.000137	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	4.9e-06	0.000137	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MYC—osteoporosis	4.86e-06	0.000136	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	4.85e-06	0.000135	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—POMC—osteoporosis	3.97e-06	0.000111	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6—osteoporosis	3.7e-06	0.000103	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6—osteoporosis	3.69e-06	0.000103	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6—osteoporosis	3.65e-06	0.000102	CbGpPWpGaD
